REVIEW
Published on 29 Jul 2024
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
doi 10.3389/fonc.2024.1414112
- 1,268 views
- Frontiers in Oncology
- Gynecological Oncology
- Research Topics
- PARP inhibitors resistance: new insights in ovarian cancer therapy
PARP inhibitors resistance: new insights in ovarian cancer therapy
2,680
Total downloads
9,086
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 27 Jun 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
doi 10.3389/fonc.2024.1402851
- 1,719 views
ORIGINAL RESEARCH
Published on 25 Apr 2024
RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer
doi 10.3389/fonc.2024.1351778
- 1,341 views
REVIEW
Published on 13 Mar 2024
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges
doi 10.3389/fonc.2024.1354427
- 3,048 views
- 5 citations
Published in
Frontiers in Oncology
- Gynecological Oncology
Impact
- 9,086Topic views
- 5,624Article views
- 2,680Article downloads